Protein Carbonyl Level Causes Oxidative Protein Damage In Diabetics
Oxidative stress is considered to be a unifying link between diabetes ...A new study which appears in the May-June issue of Journal of Di...Researchers from the Department of Biochemistry and Nephrology Medi...It was found that protein carbonyl (PCO) content increased significa...Data from this study confirm that plasma carbonyl level is a relevan...
Oxidative stress is considered to be a unifying link between diabetes mellitus (DM) and its complications, including nephropathy.// There is sufficient evidence on increased production of oxidants and decreased level of antioxidants in diabetic patients. The dialysis procedure contributes to oxidative stress. An increase in oxidative stress may contribute to the development of oxidative protein damage in diabetic patients.
A new study, which appears in the May-June issue of Journal of Diabetes and its Complications was conducted to reveal the effects of diabetes and hemodialysis (HD) on oxidative modifications of plasma proteins.
Researchers from the Department of Biochemistry and Nephrology, Medical Faculty, Akdeniz measured reactive carbonyl derivates (PCO), protein thiol (P-SH), and reduced glutathione (GSH) levels in Type 2 diabetic (DM) and diabetic hemodialysed patients (DHD) and in healthy control participants.
It was found that protein carbonyl (PCO) content increased significantly in all patient groups relative to the controls. The dialysis procedure caused an additional increase in PCO levels in DHD patients before and after dialysis compared with the level in DM patients. There was a significant decrease in P-SH levels in DHD patients compared with the level in healthy participants and DM patients. There was no significant difference in the whole blood GSH levels between the DM patients and control participants. It was significantly higher in DHD patients in comparison to the DM patients.
Data from this study confirm that plasma carbonyl level is a relevant marker of protein oxidation in both DM and diabetic HD patients. Increased ROS may interact with proteins, leading to oxidative modifications of proteins.
The authors conclude that PCO level increases in DM patients, and this increase is more profound in DHD patients, indicating that both diabetes and dialysis contribute to increased protein oxidat '"/>
(Date:12/4/2009)...4 CareTech Solutions , an informa... provider for hospitals and health systems, announ...es earned ten awards in the Strategic Communicati...e awards were accepted by CareTech Solutions Execu...Catallo, at the 13th annual Greystone Internet Hea...
(Date:12/4/2009)...an be an effective way to improve moderate to seve... university Karolinska Institutet report. Those wi...ted most from weight loss. , "Our findings sugg... strategy for sleep apnoea in obese men," says Kar...e study. , Sleep apnoea the temporary cessation...
(Date:12/4/2009)... progress has been made over the last 15 years in ... treat epilepsy and its complications. Yet this p...t of the 50 million people around the world, inclu...e United States who have the disorder, , Accordi...American Epilepsy Society (AES), there is an enorm...
(Date:12/4/2009)...hguard (PPM) - certified Dr. Nassery serves local ... and options , Miami Beac...Dr. H.A. Nassery contributes to local athletic com...young athletes and offering the Pure Power Mouthgu...ated Ashley Kimmel, a student at Miami Country Day...
(Date:12/4/2009)...and what 2-D images represent, researchers say , ...eys can recognize photographs of other monkeys the...ces in faces and figure out if they,ve seen them b...ws that capuchin monkeys can decipher the two-dime...hors noted. , The findings, reported by researc...
...hed in the medical journal Thorax a study conclude...culosis infection. The study looked at 2,401 adult...frica. The participants were surveyed about their ...
Of 1,309 current smokers or ex-smokers, 1,070...
...ug Administration (FDA) issued a public health adv...ers about the suspended marketing of Tysabri (nata...f multiple sclerosis (MS) which was approved by th...ever, it is believed that the drug has a promising...
...hat is often done as a measure for weight reductio...rt disease.
One of the most common procedure...urgery that reduces the size of the stomach and al...s to control obesity through lasting weight loss. ...
...ew discovery regarding the cells that are responsi...searchers from Wake Forest University School of Me... the thalamus area of the brain can slow the relea...tective glutamate receptors in increasing their po...
...er Cancer Institute and collaborating institutions... cancer cells where cancer-related genes may lurk....urnal Cancer Research, the researchers used single...nes were either left out or multiplied over and ov...
...cessfully treat atherosclerosis, the narrowing of ...rmine whether the drugs could also treat a similar...rrowing of the aortic valve in the heart.
...osis. For the study researchers from the United Ki...
(Date:12/4/2009)..., , WILMINGTON, Del., Dec. 4 /PRNewswire-...ounced that the US Food and Drug Administration (F...tiapine fumarate) Extended Release Tablets as adju...ults with Major Depressive Disorder (MDD). SEROQUE...by the FDA to treat both major depressive disorder...
(Date:12/3/2009)..., , ALISO VIEJO, Calif. and STATE COLLEG...SoftGenetics today announced the signing of an agr... services using SoftGenetics, NextGENe software fo... Ambry. ,, (Logo: http://www.newscom.com/cg...sheidt PhD, Ambry,s CSO said, "Our team at Ambry h...
(Date:12/3/2009)..., , SAN DIEGO, Dec. 3 /PRNewswire-FirstCa...nounced today that it has entered into a new lease...GN ) for approximately 131,000 square feet of addi...ace at The Landmark at Eastview campus in Tarrytow...3. This lease of additional space was completed ap...
...TLE, Dec. 6 Results from RESTORE 2, a,placebo-con...estigational,compound retigabine significantly red... refractory partial-onset epilepsy when a 600 mg o...i-epileptic drug (AED) therapy. Prior to,enrollmen... experiencing,seizures despite taking stable doses...
...ADELPHIA, Dec. 6 GlaxoSmithKline (NYSE: GSK ),a... RAISE (RAndomized placebo-,controlled ITP Study w...,(eltrombopag) in adults with chronic immune (idio...eived one or more prior ITP therapies. Patients,re... those on placebo to,maintain platelet counts betw...